Bio Path reported $-976K in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Bio Path USD -976K 3.62M Sep/2025
Cipla INR 6.76B 6.75B Dec/2025
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD 56.84M 63.82M Dec/2025
CSL USD 401M 96.5M Dec/2025
Grifols EUR 114.37M 34.03M Dec/2025
Karyopharm Therapeutics USD -102.2M 71.42M Dec/2025